Industry Veteran Joins Intranasal Therapeutics

Article

Intranasal Therapeutics, Inc. (ITI, Montvale, NJ, www.intranasal.com), has appointed Peter F. Young as president and chief executive officer.

Intranasal Therapeutics, Inc. (ITI, Montvale, NJ, www.intranasal.com), has appointed Peter F. Young as president and chief executive officer. Young was most recently the president and CEO of AlphaVax, a North Carolina-based biotechnology company. While at AlphaVax, Young grew that company from six to 75 employees and advanced its technology from the academic bench to human clinical trials.

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.